New CBD & THC Cannabis Oils Now Shipping To Australia From Canada
Portfolio Pulse from Jelena Martinovic
MediPharm Labs Corp. has announced the launch of Canadian-produced GMP Beacon Medical cannabis oil and inhalation cartridges in the Australian medical marijuana market. The products include a high CBD Isolate oil, a balanced oil, and a THC dominant full spectrum oil. The company has started shipping inhalation cartridges to patients and plans to ship cannabis oils from Canada this week. MediPharm holds an Australian GMP license from the Therapeutic Goods Administration (TGA), complemented by its GMP status from Health Canada and the US FDA.
September 28, 2023 | 11:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MediPharm's expansion into the Australian market with its cannabis products could potentially increase its revenue and market share. The company's stock traded 0.2686% higher at $0.056 per share at the time of the news.
The news of MediPharm's expansion into the Australian market with its cannabis products is directly relevant to the company and could potentially increase its revenue and market share. This could have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100